Poster De Conférence Année : 2024

Automated 68Ga-PSMA-PET Total Metabolic Tumor Volume (TMTV) Extraction for Predicting PSA Change in 177Lu-PSMA Therapy

Résumé

Background: Advanced prostate cancer remains a significant challenge in oncology. Radiopharmaceutical therapy with 177Lu-PSMA has emerged as a promising treatment, with 68Ga-PSMA PET/CT imaging playing a crucial role in evaluating disease extent and treatment response. This study aims to assess the correlation between PET/CT imaging features and serum PSA levels to refine patient eligibility and predict therapy outcomes. Methods: Data from 78 male patients undergoing 177Lu-PSMA therapy (1–6 cycles of 7.4 GBq) were analyzed. Imaging included 68Ga-PSMA PET/CT and SPECT post-treatment. Automated segmentation using "TotalSegmentator" delineated lesions, excluding physiological uptake in organs-at-risk. Total Metabolic Tumor Volume (TMTV) was calculated by subtracting organ signals and applying patient-specific thresholds. PSA nadir, defined as the lowest PSA value during treatment, was used to classify responders (≥50% reduction in PSA). Mann-Whitney U-tests and a multilayer perceptron (MLP) model assessed correlations and classification performance. Results: A significant difference in mean standardized uptake value (SUV) of TMTV was observed between responders and non-responders (p = 0.001). Classification using MLP achieved an F1-score of 0.71 for a balanced dataset and 0.48 for an unbalanced dataset. A ROC curve derived from a balanced dataset with a universal SUV threshold of 2.57 yielded an F1-score of 0.75. Conclusion: The study highlights a weak but statistically significant correlation between TMTV SUV mean and PSA response. The results emphasize the need for larger, curated datasets and refined TMTV computation for better prediction accuracy.
Fichier principal
Vignette du fichier
2024_JS_SFPM_Dijon.pptx.pdf (447.49 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
licence

Dates et versions

hal-04894173 , version 1 (17-01-2025)

Licence

Identifiants

  • HAL Id : hal-04894173 , version 1

Citer

Eduardo Rios Sanchez, David Sarrut, Jean‐noël Badel. Automated 68Ga-PSMA-PET Total Metabolic Tumor Volume (TMTV) Extraction for Predicting PSA Change in 177Lu-PSMA Therapy. SFPM, Jun 2024, Dijon, France. ⟨hal-04894173⟩
0 Consultations
0 Téléchargements

Partager

More